N6-methyladenosine modification of CENPK mRNA by ZC3H13 promotes cervical cancer stemness and chemoresistance

被引：0
|
作者：
Xian Lin
Feng Wang
Jian Chen
Jing Liu
Yi-Bin Lin
Li Li
Chuan-Ben Chen
Qin Xu
机构：
[1] Fujian Cancer Hospital and Fujian Medical University Cancer Hospital,Departments of Gynecology
[2] Fujian Medical University,Department of Radiation Oncology
[3] Fujian Cancer Hospital and Fujian Medical University Cancer Hospital,Shenzhen Key Laboratory of Immunity and Inflammatory Diseases
[4] Fujian Medical University,Outpatient Department, Fujian Hospital of People’s Armed Police
[5] Peking University Shenzhen Hospital,undefined
[6] Shenzhen Peking University-the Hong Kong University of Science and Technology Medical Center,undefined
[7] Fujian Medical University,undefined
来源：
Military Medical Research | / 9卷
关键词：
-methyladenosine; Centromere protein K; Cervical cancer; Stemness; Chemoresistance;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] N6-methyladenosine modification of CENPK mRNA by ZC3H13 promotes cervical cancer stemness and chemoresistance
    Lin, Xian
    Wang, Feng
    Chen, Jian
    Liu, Jing
    Lin, Yi-Bin
    Li, Li
    Chen, Chuan-Ben
    Xu, Qin
    MILITARY MEDICAL RESEARCH, 2022, 9 (01)
  • [2] N6-methyladenosine modification of CENPK mRNA by ZC3H13 promotes cervical cancer stemness and chemoresistance
    Xian Lin
    Feng Wang
    Jian Chen
    Jing Liu
    Yi-Bin Lin
    Li Li
    Chuan-Ben Chen
    Qin Xu
    Military Medical Research, 2022, (05) : 576 - 591
  • [3] ZC3H13 Accelerates Keloid Formation by Mediating N6-methyladenosine Modification of HIPK2
    Fu, Manni
    Chen, Yongjun
    Shi, Xian
    BIOCHEMICAL GENETICS, 2024, 62 (03) : 1857 - 1871
  • [4] N6-Methyladenosine modification of YY1 mRNA promotes cervical cancer tumorigenesis
    Arumugam, P.
    Jayaseelan, V. P.
    ANNALS OF ONCOLOGY, 2022, 33 : S388 - S388
  • [5] Analysis of N6-Methyladenosine Methyltransferase Reveals METTL14 and ZC3H13 as Tumor Suppressor Genes in Breast Cancer
    Gong, Peng-Ju
    Shao, You-Cheng
    Yang, Yan
    Song, Wen-Jing
    He, Xin
    Zeng, Yi-Fan
    Huang, Si-Rui
    Wei, Lei
    Zhang, Jing-Wei
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [6] ZC3H13 knockdown enhances the inhibitory effect of sevoflurane on gastric cancer cell malignancy by regulating the N6-methyladenosine modification of the lncRNA DLX6-AS1
    Liu, Chundong
    Chen, Zeguang
    HELIYON, 2024, 10 (16)
  • [7] N6-methyladenosine modification of B7-H3 mRNA promotes the development and progression of colorectal cancer
    Chen, Rui
    Su, Fei
    Zhang, Tao
    Wu, Dongjin
    Yang, Jingru
    Guan, Quanlin
    Chai, Chen
    ISCIENCE, 2024, 27 (02)
  • [8] N6-Methyladenosine Writer Gene ZC3H13 Predicts Immune Phenotype and Therapeutic Opportunities in Kidney Renal Clear Cell Carcinoma
    Guo, Tao
    Duan, Hongxiang
    Chen, Jinbo
    Liu, Jinhui
    Othmane, Belaydi
    Hu, Jiao
    Li, Huihuang
    Zu, Xiongbing
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [9] Identification and validation of the N6-methyladenosine RNA methylation regulator ZC3H13 as a novel prognostic marker and potential target for hepatocellular carcinoma
    Wu, Shuang
    He, Guifang
    Liu, Shihai
    Cao, Yongxian
    Geng, Chao
    Pan, Huazheng
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2022, 19 (04): : 618 - 630
  • [10] N6-methyladenosine modification of ITGA6 mRNA promotes the development and progression of bladder cancer
    Jin, Huan
    Ying, Xiaoling
    Que, Biao
    Wang, Xiaoxue
    Chao, Yinghui
    Zhang, Haiqing
    Yuan, Zusen
    Qi, Defeng
    Lin, Shuibin
    Min, Wang
    Yang, Mei
    Ji, Weidong
    EBIOMEDICINE, 2019, 47 : 195 - 207
12345